0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Invited Critique |

Treatment Strategy for Intraductal Papillary Mucinous Neoplasm of the Pancreas Based on Malignant Predictive Factors—Invited Critique

David B. Adams, MD
Arch Surg. 2009;144(4):349-350. doi:10.1001/archsurg.2008.590.
Text Size: A A A
Published online

Extract

The Nobel physicist Sir Ernest Rutherford said, “all science is either physics or stamp collecting.”1 It is difficult to realize that surgical science is frequently closer to stamp collecting than to physics. We examine information from our collection of patients and try to define disease on the basis of the data at hand. Much is missing from the record, and we overcome this with a variety of statistical tools and insightful leaps of imagination. The question goes begging, “What do we know about what we do not know?” With IPMN we constantly need to remind ourselves that there is much we do not know. The conventional wisdom is that branch-duct IPMNs are less aggressive than main-duct IPMNs, malignancy is more common in older patients, malignancy is found in about 70% of resected main-duct IPMNs, recurrence is rare after resection of noninvasive IPMNs, and recurrence occurs in the majority after resection of invasive IPMNs.2 Cyst fluid CEA was found to be the most accurate test to differentiate mucinous from nonmucinous cystic lesions, with an optimal cutoff of 192 ng/mL.3 In this report from Hirono and colleagues, the CEA bar is set at 110 ng/mL as an independent predictive factor for malignancy. Other investigators found cyst fluid CEA to be of limited value in differentiating benign from malignant IPMNs.4 Clearly a better marker for dysplasia and malignancy is needed as an aid to operative selection of patients. Until then, careful history, physical examination, and laboratory and radiologic examination with computed tomography, magnetic resonance imaging, and endoscopic ultrasonography will be used with cyst fluid analysis to assess patient risk for operative and expectant management. The natural course of the disease will be clarified as we gather this information and examine the data past and present to better predict the future behavior of IPMNs.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles
Jobs
brightcove.createExperiences();